Browse by category
GLP-1 RAs show cardiovascular benefits beyond weight loss
Semaglutide reduces COVID-19 related deaths in patients with obesity and CVD
European Society of Cardiology Obesity Consensus Statement
One in seven Medicare beneficiaries with high BMI and established CVD may qualify for OMMs adding $34 billion to costs
Look AHEAD study: T2DM remission associated with lower rates of heart and kidney disease
How bariatric surgery reduces the risk of developing cardiovascular disease
CPAP reduces risk of dying from cardiovascular disease for patients with obstructive sleep apnoea
Obesity-related cardiovascular disease deaths tripled between 1999 and 2020
CVD with obesity associated with more illness, death and medical costs, than obesity alone
Surgery associated with lower risk of incidents of major adverse CV and all-cause mortality